Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma
埃洛妥珠单抗联合泊马度胺、硼替佐米和地塞米松治疗复发难治性多发性骨髓瘤
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024014717
Yee, Andrew J; Laubach, Jacob P; Campagnaro, Erica L; Lipe, Brea C; Nadeem, Omar; Friedman, Robb S; Cole, Craig E; O'Donnell, Elizabeth K; Bianchi, Giada; Branagan, Andrew R; Schlossman, Robert L; Shapiro, Samantha J; Harrington, Cynthia C; Burke, Jill N; Gammon, Marilyn T; Lively, Kathleen J; Reimonn, Cassandra A; Andrade, Danielle X; Redd, Robert; Lohr, Jens G; Anderson, Kenneth C; Richardson, Paul G; Raje, Noopur S